Literature DB >> 8670733

Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro.

J Tirado-Angel1, M M Gabriel, L A Wilson, D G Ahearn.   

Abstract

We determined the relative minimal inhibitory and minimal amoebicidal concentrations of chlorhexidine digluconate and polyhexamethylene biguanide for four species of Acanthamoeba. The amoebae were grown in peptone-glucose-yeast extract broth for 72 h in tissue culture flasks. Either washed trophozoites (approximately 10(5)) or cysts (approximately 10(5)) were incubated in the enrichment broth in 96 well microtiter trays. Antimicrobial concentrations of the biguanides were determined from microscopic examinations of methylene blue uptake and from subcultures. In general, killing was time dependent. Minimal amoebicidal concentrations at 24 h ranged from 50 to 100 mg/ml and to as low as 25 mg/ml by 72 h. Trophozoites were killed more rapidly than cysts. Both biguanides had similar levels of activity. A synergistic combination of chlorhexidine and polyhexamethylene biguanide (total concentration 25 mg/ml) was most evident for A. castellanii and A. polyphaga. Cysts of A. culbertsoni and A. hatchetti stained more rapidly after exposure to the combination of biguanides than to the single biguanides, but there were no statistically significant differences in the final numbers of dead or stained cysts after exposure to the combination or to the single biguanides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670733     DOI: 10.3109/02713689608997418

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

1.  Flow cytometry for determination of the efficacy of contact lens disinfecting solutions against Acanthamoeba spp.

Authors:  R N Borazjani; L L May; J A Noble; S V Avery; D G Ahearn
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

2.  Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Authors:  Ricardo Lamy; Elliot Chan; Samuel D Good; Vicky Cevallos; Travis C Porco; Jay M Stewart
Journal:  Clin Exp Ophthalmol       Date:  2016-02-23       Impact factor: 4.207

3.  In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea.

Authors:  S Gatti; C Cevini; A Bruno; G Penso; P Rama; M Scaglia
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis.

Authors:  S Sharma; P Garg; G N Rao
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

5.  Double-biguanide therapy for resistant acanthamoeba keratitis.

Authors:  Giulio Ferrari; Stanislav Matuska; Paolo Rama
Journal:  Case Rep Ophthalmol       Date:  2011-11-05

6.  Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis.

Authors:  Firoozeh Rahimi; Seyed Mohammad Nasser Hashemian; Mohammadreza Falah Tafti; Mohammadali Zare Mehjerdi; Mona Seyed Safizadeh; Elias Khalili Pour; Bahram Bohrani Sefidan
Journal:  J Ophthalmic Vis Res       Date:  2015 Apr-Jun

7.  Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis.

Authors:  Bhupesh Bagga; Prashant Garg; Joveeta Joseph; Ashik Mohamed; Paavan Kalra
Journal:  Indian J Ophthalmol       Date:  2020-03       Impact factor: 1.848

8.  Phagocytosis affects biguanide sensitivity of Acanthamoeba spp.

Authors:  Judith A Noble; Donald G Ahearn; Simon V Avery; Sidney A Crow
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.